Fibrogen Stock Price on May 7, 2025
| FGEN Stock | USD 6.93 0.04 0.58% |
If you're considering investing in FibroGen Stock, it is important to understand the factors that can impact its price. As of today, the current price of FibroGen stands at 6.93, as last reported on the 5th of August, with the highest price reaching 7.10 and the lowest price hitting 6.72 during the day. FibroGen secures Sharpe Ratio (or Efficiency) of -0.022, which denotes the company had a -0.022 % return per unit of standard deviation over the last 3 months. FibroGen exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm FibroGen's Coefficient Of Variation of (5,149), mean deviation of 3.85, and Standard Deviation of 5.6 to check the risk estimate we provide. At this time, FibroGen's Capital Stock is very stable compared to the past year. As of the 5th of August 2025, Stock Based Compensation is likely to grow to about 44.7 M, though Total Stockholder Equity is likely to grow to (174.5 M). . As of the 5th of August 2025, Price To Sales Ratio is likely to drop to 1.70. In addition to that, Price Earnings Ratio is likely to drop to -1.17. FibroGen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Price Book 53.8258 | Enterprise Value Ebitda (0.17) | Price Sales 3.9805 | Shares Float 3.6 M | Wall Street Target Price 250 |
Related Headline
Akebia Ther Headline on 7th of May 2025
Earnings To Watch Akebia Therapeutics Inc Reports Q1 2025 Re... by gurufocus.com
Akebia Therapeutics Inc is set to release its Q1 2025 earnings on May 8, 2025. The consensus estimate for Q1 2025 revenue is 44.88 million, and the earn
FibroGen Valuation on May 7, 2025
It is possible to determine the worth of FibroGen on a given historical date. On May 7, 2025 FibroGen was worth 7.38 at the beginning of the trading date compared to the closed value of 8.15. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of FibroGen stock. Still, in general, we apply an absolute valuation method to find FibroGen's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of FibroGen where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against FibroGen's related companies.
| Open | High | Low | Close | Volume | |
| 7.75 | 8.00 | 7.03 | 7.28 | 30,376 | |
05/07/2025 | 7.38 | 8.48 | 7.38 | 8.15 | 39,194 |
| 8.25 | 8.26 | 7.88 | 7.99 | 10,874 |
| Backtest FibroGen | | | FibroGen History | | | FibroGen Valuation | Previous | Next |
FibroGen Trading Date Momentum on May 7, 2025
| On May 08 2025 FibroGen was traded for 7.99 at the closing time. The top price for the day was 8.26 and the lowest listed price was 7.88 . The trading volume for the day was 10.9 K. The trading history from May 8, 2025 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.96% . The overall trading delta against the current closing price is 6.38% . |
FibroGen Fundamentals Correlations and Trends
By evaluating FibroGen's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among FibroGen's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. FibroGen financial account trend analysis is a perfect complement when working with valuation or volatility modules.About FibroGen Stock history
FibroGen investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for FibroGen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in FibroGen will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing FibroGen stock prices may prove useful in developing a viable investing in FibroGen
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 100 M | 81 M | |
| Net Loss | -264.3 M | -251.1 M |
FibroGen Quarterly Net Working Capital |
|
FibroGen Stock Technical Analysis
FibroGen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
FibroGen Period Price Range
Low | August 5, 2025
| High |
0.00 | 0.00 |
FibroGen cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
FibroGen August 5, 2025 Market Strength
Market strength indicators help investors to evaluate how FibroGen stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading FibroGen shares will generate the highest return on investment. By undertsting and applying FibroGen stock market strength indicators, traders can identify FibroGen entry and exit signals to maximize returns
FibroGen Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for FibroGen's price direction in advance. Along with the technical and fundamental analysis of FibroGen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of FibroGen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (0.85) | |||
| Treynor Ratio | (0.06) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in FibroGen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FibroGen. If investors know FibroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FibroGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.536 | Earnings Share (30.00) | Revenue Per Share | Quarterly Revenue Growth (0.89) | Return On Assets |
The market value of FibroGen is measured differently than its book value, which is the value of FibroGen that is recorded on the company's balance sheet. Investors also form their own opinion of FibroGen's value that differs from its market value or its book value, called intrinsic value, which is FibroGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FibroGen's market value can be influenced by many factors that don't directly affect FibroGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FibroGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if FibroGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FibroGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.